More Than Half of U.S. Abortions Now Done With Pills

THURSDAY, Feb. 24, 2022 (HealthDay News) -- An increase in telemedicine during the pandemic and easier access to prescription drugs to end a pregnancy may help explain why more than half of U.S. abortions are now done with a combination of medicines instead of surgery, researchers report.
The percentage of abortions done with U.S. Food and Drug Administration-approved mifepristone pills rose from about 44 percent in 2019 to 54 percent in 2020, according to preliminary numbers from the Guttmacher Institute, a research group that supports abortion rights.
Two factors may have contributed to the increase in the use of prescription pills for abortions, Guttmacher researcher Rachel Jones suggested. During the pandemic, there was a rise in the use of telemedicine and the FDA started to allow abortion pills to be mailed to patients instead of requiring in-person visits to get them, a change that became permanent last December. That means that millions of women can now get a prescription through an online consultation and receive the pills through the mail.
The FDA approved mifepristone in 2000, and use of the abortion pills has been rising since then.
Abortion opponents have stepped up efforts to get state legislatures to place additional restrictions on medical abortions. So far this year, 16 state legislatures have proposed bans or restrictions on medication abortion, according to the Guttmacher Institute. It said that mailing abortion pills is banned in three states -- Arizona, Arkansas, and Texas -- and that 32 states require these medications to be prescribed by physicians even though other medicines can be prescribed by physician assistants and other health care providers.
Related Posts
Fruquintinib Provides Meaningful Benefit in Refractory Metastatic CRC
THURSDAY, July 20, 2023 (HealthDay News) -- For patients with refractory...
COVID’s Global Death Toll May Be 3 Times Official Numbers
FRIDAY, March 11, 2022 (HealthDay News) -- If you think the reported worldwide...
Myocarditis Up After Second Dose of mRNA-1273 Versus BNT162b2
WEDNESDAY, Nov. 9, 2022 (HealthDay News) -- The rates of myocarditis and...
AHA News: 63 Years Ago, She Had Pioneering Open-Heart Surgery at Age 4
FRIDAY, Aug. 5, 2022 (American Heart Association News) -- At Susan Mangini's...
